2009Journal of Taishan Medical CollegeRequires access

The research of the effect of curcumin on dopaminergic neurons in mouse model of parkinson's disease

Lingzhong Xu

Open publisher page 2 citations

Abstract

Objective:To investigate the protective effect of Curcumin on doparminergic neurons.Methods: C57BL6 mice were randomly divided into three groups: control group(DMSO,ip),MPTP group(15 mg/kg,ip) and Curcumin-pretreatment(10 mg/kg,ip) group.The changes of tyrosine hydroxylase(TH) and dopamine transport(DAT) gene expression in substantia nigra(SN) were detected by using reverse transcription-polymerase chain reaction(RT-PCR).The contents of DA and its metabolites dihydroxy-phenylacetic acid(DOPAC) were determined by high performance liquid chromatography-electrical chemical detection(HPLC-ECD).Results: Curcumin pretreatment could prevent the MPTP-induced decrease of TH and DAT gene ex-pression(P0.01).MPTP significantly decreased the levels of dopamine(DA) and its metabolites dihydroxy-phenylacetic acid(DOPAC) in the striatum,which could be restored by Curcumin pretreatment P0.01).Conclusion: Curcumin has neuroprotective effects on dopaminergic neurons against MPTP-induced mouse model of PD.

About this research paper

What this paper is about

Objective:To investigate the protective effect of Curcumin on doparminergic neurons.Methods: C57BL6 mice were randomly divided into three groups: control group(DMSO,ip),MPTP group(15 mg/kg,ip) and Curcumin-pretreatment(10 mg/kg,ip) group.The changes of tyrosine hydroxylase(TH) and dopamine transport(DAT) gene expression in substantia nigra(SN) were detected by using reverse transcription-polymerase chain reaction(RT-PCR).The contents of DA and its metabolites dihydroxy-phenylacetic acid(DOPAC) were determined by high performance liquid chromatography-electrical chemical detection(HPLC-ECD).Results: Curcumin pretreatment could prevent the MPTP-induced decrease of TH and DAT gene ex-pression(P0.01).MPTP significantly decreased the levels of dopamine(DA) and its metabolites dihydroxy-phenylacetic acid(DOPAC) in the striatum,which could be restored by Curcumin pretreatment P0.01).Conclusion: Curcumin has neuroprotective effects on dopaminergic neurons against MPTP-induced mouse model of PD.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the protective effect of Curcumin on doparminergic neurons.Methods: C57BL6 mice were randomly divided into three groups: control group(DMSO,ip),MPTP group(15 mg/kg,ip) and Curcumin-pretreatment(10 mg/kg,ip) group.The changes of tyrosine hydroxylase(TH) and dopamine transport(DAT) gene expression in substantia nigra(SN) were detected by using reverse transcription-polymerase chain reaction(RT-PCR).The contents of DA and its metabolites dihydroxy-phenylacetic acid(DOPAC) were determined by high performance liquid chromatography-electrical chemical detection(HPLC-ECD).Results: Curcumin pretreatment could prevent the MPTP-induced decrease of TH and DAT gene ex-pression(P0.01).MPTP significantly decreased the levels of dopamine(DA) and its metabolites dihydroxy-phenylacetic acid(DOPAC) in the striatum,which could be restored by Curcumin pretreatment P0.01).Conclusion: Curcumin has neuroprotective effects on dopaminergic neurons against MPTP-induced mouse model of PD.

Key concepts: MPTP, Curcumin, Dopaminergic, Substantia nigra, Tyrosine hydroxylase, Dopamine, Chemistry, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
The research of the effect of curcumin on dopaminergic neurons in mouse model of parkinson's disease — Research Paper | ScholarLens